echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Bayer Global Executive Vice President and President of China and Asia Pacific Region Jiang Wei retires

    Bayer Global Executive Vice President and President of China and Asia Pacific Region Jiang Wei retires

    • Last Update: 2021-06-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to Bayer China’s public information, based on family arrangements, Mr.
    Jiang Wei, member of the Global Executive Committee of the Prescription Drug Division of Bayer Group, Global Executive Vice President and President of China and Asia Pacific, and President of Bayer Group Greater China, decided not to renew the contract And retired from Bayer Group.

    On July 1, 2021, Ms.


    Zhou Xiaolan, the current Senior Vice President of Bayer Group Prescription Drug Division and President of Asia Pacific Region, will take over the positions of member of the Global Executive Committee of Bayer Group Prescription Drug Division and President of China Region.


    Mr.


    Jiang Wei will continue to serve as the President of Bayer Group Greater China and will be responsible for the Asia-Pacific region until September 30, 2021.


    According to Bayer China’s public information, based on family arrangements, Mr.
    Jiang Wei, member of the Global Executive Committee of the Prescription Drug Division of Bayer Group, Global Executive Vice President and President of China and Asia Pacific, and President of Bayer Group Greater China, decided not to renew the contract And retired from Bayer Group.

    On July 1, 2021, Ms.


    Zhou Xiaolan, the current Senior Vice President of Bayer Group Prescription Drug Division and President of Asia Pacific Region, will take over the positions of member of the Global Executive Committee of Bayer Group Prescription Drug Division and President of China Region.


    Mr.


    Jiang Wei will continue to serve as the President of Bayer Group Greater China and will be responsible for the Asia-Pacific region until September 30, 2021.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.